MARKET

MMSI

MMSI

Merit Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

29.77
-0.23
-0.77%
After Hours: 29.78 +0.01 +0.02% 16:11 12/13 EST
OPEN
29.91
PREV CLOSE
30.00
HIGH
30.02
LOW
29.46
VOLUME
950.65K
TURNOVER
--
52 WEEK HIGH
63.64
52 WEEK LOW
19.50
MARKET CAP
1.64B
P/E (TTM)
76.49
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MMSI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MMSI News

  • MMSI LOSS NOTICE: TOP RANKED ROSEN LAW FIRM Reminds Merit Medical Systems, Inc. Investors of Important Deadline in Securities Class Action MMSI
  • Business Wire.4h ago
  • IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Merit Medical Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  • ACCESSWIRE.23h ago
  • CLASS ACTION UPDATE for ADMS, REAL and MMSI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  • ACCESSWIRE.1d ago
  • SHAREHOLDER ALERT - Merit Medical Systems, Inc. (MMSI) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 3, 2020
  • GlobeNewswire.1d ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.35%
Healthcare Equipment & Supplies
+0.24%

Hot Stocks

Name
Price
%Change

About MMSI

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.
More

Webull offers Merit Medical Systems, Inc. (MMSI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.